Literature DB >> 23036532

Differential regulation of fibrinogen γ chain splice isoforms by interleukin-6.

Chantelle M Rein-Smith1, Nathan W Anderson, David H Farrell.   

Abstract

INTRODUCTION: Fibrinogen is a major structural protein in blood clots, and is also a well-known acute phase reactant. The γ chain gene of fibrinogen has two alternative splice variants, γA and γ' chains. γ' fibrinogen constitutes about 7% of total fibrinogen. Total fibrinogen levels and γ' fibrinogen levels have been associated with cardiovascular disease, but the mechanisms regulating the production of the two isoforms are unknown. Several inflammatory cytokines are known to influence the production of total fibrinogen, but the role of cytokines in the production of γ' fibrinogen has not been examined. However, epidemiologic studies have shown an association between γ' fibrinogen levels and inflammatory markers in humans.
MATERIALS AND METHODS: The expression of γ' fibrinogen and total fibrinogen by HepG2 liver cells was quantitated after treatment with interleukin-1β, transforming growth factor-β, tumor necrosis factor-α, and interleukin-6.
RESULTS: Interleukin-1β, transforming growth factor-β, and tumor necrosis factor-α, known down-regulators of total fibrinogen synthesis, also downregulate γ' fibrinogen synthesis in HepG2 cells. However, interleukin-6 differentially up-regulates the production of total and γ' fibrinogen, leading to a 3.6-fold increase in γA mRNA, but an 8.3-fold increase in γ' mRNA.
CONCLUSIONS: These findings indicate that γ' fibrinogen is disproportionately up-regulated by inflammatory responses induced by interleukin-6.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23036532      PMCID: PMC3530012          DOI: 10.1016/j.thromres.2012.09.017

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  34 in total

1.  Influence of gamma' fibrinogen splice variant on fibrin physical properties and fibrinolysis rate.

Authors:  J P Collet; C Nagaswami; D H Farrell; G Montalescot; J W Weisel
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-12-01       Impact factor: 8.311

2.  Gamma' fibrinogen: evaluation of a new assay for study of associations with cardiovascular disease.

Authors:  Rehana S Lovely; Steven C Kazmierczak; Joseph M Massaro; Ralph B D'Agostino; Christopher J O'Donnell; David H Farrell
Journal:  Clin Chem       Date:  2010-03-26       Impact factor: 8.327

3.  Association between γ' fibrinogen levels and inflammation.

Authors:  Kristine S Alexander; Theresa E Madden; David H Farrell
Journal:  Thromb Haemost       Date:  2010-12-21       Impact factor: 5.249

4.  Signal-dependent regulation of splicing via phosphorylation of Sam68.

Authors:  Nathalie Matter; Peter Herrlich; Harald König
Journal:  Nature       Date:  2002-12-12       Impact factor: 49.962

5.  Regulation of alternative pre-mRNA splicing by the ERK MAP-kinase pathway.

Authors:  S Weg-Remers; H Ponta; P Herrlich; H König
Journal:  EMBO J       Date:  2001-08-01       Impact factor: 11.598

6.  Interleukin 1beta inhibits interleukin 6-mediated rat gamma fibrinogen gene expression.

Authors:  Z Zhang; G M Fuller
Journal:  Blood       Date:  2000-11-15       Impact factor: 22.113

7.  Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis B surface antigen.

Authors:  B B Knowles; C C Howe; D P Aden
Journal:  Science       Date:  1980-07-25       Impact factor: 47.728

8.  Association of gammaA/gamma' fibrinogen levels and coronary artery disease.

Authors:  Rehana S Lovely; Lisa A Falls; Hamid A Al-Mondhiry; Charles E Chambers; Gary J Sexton; Hanyu Ni; David H Farrell
Journal:  Thromb Haemost       Date:  2002-07       Impact factor: 5.249

9.  Interleukin-1beta but not IL-1alpha binds to fibrinogen and fibrin and has enhanced activity in the bound form.

Authors:  Abha Sahni; Min Guo; Sanjeev K Sahni; Charles W Francis
Journal:  Blood       Date:  2004-03-23       Impact factor: 22.113

10.  Functional analysis of interleukin 6 response elements (IL-6REs) on the human gamma-fibrinogen promoter: binding of hepatic Stat3 correlates negatively with transactivation potential of type II IL-6REs.

Authors:  Hai Ou Duan; Patricia J Simpson-Haidaris
Journal:  J Biol Chem       Date:  2003-08-04       Impact factor: 5.157

View more
  15 in total

Review 1.  Fibrinogen, red blood cells, and factor XIII in venous thrombosis.

Authors:  B L Walton; J R Byrnes; A S Wolberg
Journal:  J Thromb Haemost       Date:  2015-06       Impact factor: 5.824

2.  Fibrin, γ'-fibrinogen, and transclot pressure gradient control hemostatic clot growth during human blood flow over a collagen/tissue factor wound.

Authors:  Ryan W Muthard; John D Welsh; Lawrence F Brass; Scott L Diamond
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-01-22       Impact factor: 8.311

3.  Lack of association of plasma gamma prime (γ') fibrinogen with incident cardiovascular disease.

Authors:  Duke Appiah; Susan R Heckbert; Mary Cushman; Bruce M Psaty; Aaron R Folsom
Journal:  Thromb Res       Date:  2016-04-28       Impact factor: 3.944

4.  Ligustrazine reverts anthracycline chemotherapy resistance of human breast cancer by inhibiting JAK2/STAT3 signaling and decreasing fibrinogen gamma chain (FGG) expression.

Authors:  Yu-Lin Liu; Ze-Xuan Yan; Yu Xia; Xiao-Ye Xie; Kai Zhou; Li-Li Xu; Yan-Long Shi; Qiang Wang; Jing-Wang Bi
Journal:  Am J Cancer Res       Date:  2020-03-01       Impact factor: 6.166

5.  The fibrinogen γA/γ' isoform does not promote acute arterial thrombosis in mice.

Authors:  B L Walton; T M Getz; W Bergmeier; F-C Lin; S Uitte de Willige; A S Wolberg
Journal:  J Thromb Haemost       Date:  2014-05       Impact factor: 5.824

6.  Primed to Understand Fibrinogen in Cardiovascular Disease.

Authors:  Alisa S Wolberg
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-01       Impact factor: 8.311

7.  Prognostic utility of biochemical markers of cardiovascular risk: impact of biological variability.

Authors:  Kristine S Alexander; Steven C Kazmierczak; Caryn K Snyder; Jon A Oberdorf; David H Farrell
Journal:  Clin Chem Lab Med       Date:  2013-09       Impact factor: 3.694

8.  γ' fibrinogen levels are associated with blood clot strength in traumatic brain injury patients.

Authors:  David H Farrell; Elizabeth A Rick; Elizabeth N Dewey; Martin A Schreiber; Susan E Rowell
Journal:  Am J Surg       Date:  2019-12-28       Impact factor: 2.565

9.  Association of Plasma γ' Fibrinogen With Incident Cardiovascular Disease: The Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  Duke Appiah; Pamela J Schreiner; Richard F MacLehose; Aaron R Folsom
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-10-22       Impact factor: 8.311

10.  Fibrinogen and clot-related phenotypes determined by fibrinogen polymorphisms: Independent and IL-6-interactive associations.

Authors:  H Toinét Cronjé; Cornelie Nienaber-Rousseau; Lizelle Zandberg; Zelda de Lange; Fiona R Green; Marlien Pieters
Journal:  PLoS One       Date:  2017-11-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.